Confo Therapeutics appoints Paolo Vicini as Chief Development Officer4. June 2020|In Portfolio News|By eazee-designstudioConfo Therapeutics today announced the appointment of Paolo Vicini in the newly-created position of CDO effective June 1, 2020.With two decades of leadership and scientific experience in pharmaceutical research and development, Dr. Vicini will apply his experience in translational and clinical sciences to support the Company as it moves its GPCR modulating small molecules through preclinical studies and into the clinic. PrevNext
